Worsening of borderline symptoms under reboxetine treatment.
Anghelescu
Ion
I
Jänen
Britta
B
Schindler
Frank
F
Lammers
Claas-Hinrich
CH
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use*; D000328:Adult; D001883:Borderline Personality Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use*; D000077593:Reboxetine
D018759:Adrenergic Uptake Inhibitors; D009025:Morpholines; D000077593:Reboxetine